_id

695fb6f7c2e91020a7bd422e

Ticker

0HNC.LSE

Name

BioMarin Pharmaceutical Inc.

Exchange

LSE

Address

770 Lindaro Street, San Rafael, CA, United States, 94901

Country

UK

Sector

Industry

Currency

USD

Website

https://www.biomarin.com

Description

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NAGLAZYME, a recombinant form of N- acetylgalactosamine 4-sulfatase for patients with MPS VI; and PALYNZIQ, a PEGylated recombinant phenylalanine (Phe) ammonia lyase enzyme delivered through subcutaneous injection to reduce blood Phe concentrations. It also develops BRINEURA, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; ALDURAZYME, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase; KUVAN, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria, an inherited metabolic disease; and ROCTAVIAN, an adeno associated virus vector for the treatment of severe hemophilia A. The company's products under development include BMN 333, a longer-acting CNP for the treatment of multiple growth disorders, such as achondroplasia and hypochondroplasia; BMN 349, an oral therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency; and BMN 351, an oligonucleotide for the treatment of duchenne muscular dystrophy. It serves specialty pharmacies, hospitals, non-U.S. government agencies, distributors, and pharmaceutical wholesalers. The company has license and collaboration agreements with Catalyst Pharmaceutical Partners, Inc., and Ares Trading S.A. The company was incorporated in 1996 and is based in San Rafael, California.

Last Close

60.615

Volume

538

Current Price

61.01

Change

-0.1542

Last Updated

2026-01-08T13:53:59.261Z

Ipo Date

-

Market Cap

1094018867200

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

776133000

Cost Of Revenue

140085000

Gross Profit

636048000

Operating Expenses

682740000

Operating Income

-46692000

Interest Expense

2579000

Pretax Income

-26324000

Net Income

-30744000

Eps

-0.16009831694717547

Dividends Per Share

-

Shares Outstanding

178062000

Income Tax Expense

4420000

EBITDA

-5258000

Operating Margin

-6.015979220056356

Total Other Income Expense Net

20368000

Cash

1250108000

Short Term Investments

227731000

Receivables

790266000

Inventories

1382173000

Total Current Assets

3854543000

Property Plant Equipment

1038187000

Total Assets

7614868000

Payables

389670000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

1558157000

Equity

6056711000

Bs_currency_symbol

-

Depreciation

18487000

Change In Working Capital

118927000

Cash From Operations

368685000

Capital Expenditures

28447000

Cash From Investing

-330963000

Cash From Financing

-2169000

Net Change In Cash

36292000

Cf_currency_symbol

-

PE

2.794

PB

1.934362118318011

ROE

-0.5076022283381195

ROA

-0.403736479739373

FCF

340238000

Fcf Percent

0.4383758969145752

Piotroski FScore

2

Health Score

54

Deep Value Investing Score

7.5

Defensive Investing Score

7

Dividend Investing Score

3

Economic Moat Investing Score

6.8

Garp Investing Score

4

Growth Investing Score

3

Momentum Investing Score

6

Net Net Investing Score

4

Quality Investing Score

4.5

Value Investing Score

9

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

776133000

Quarters > 0 > income Statement > cost Of Revenue

140085000

Quarters > 0 > income Statement > gross Profit

636048000

Quarters > 0 > income Statement > operating Expenses

682740000

Quarters > 0 > income Statement > operating Income

-46692000

Quarters > 0 > income Statement > interest Expense

2579000

Quarters > 0 > income Statement > pretax Income

-26324000

Quarters > 0 > income Statement > net Income

-30744000

Quarters > 0 > income Statement > eps

-0.16009831694717547

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

192032000

Quarters > 0 > income Statement > income Tax Expense

4420000

Quarters > 0 > income Statement > EBITDA

-5258000

Quarters > 0 > income Statement > operating Margin

-6.015979220056356

Quarters > 0 > income Statement > total Other Income Expense Net

20368000

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

1250108000

Quarters > 0 > balance Sheet > short Term Investments

227731000

Quarters > 0 > balance Sheet > receivables

790266000

Quarters > 0 > balance Sheet > inventories

1382173000

Quarters > 0 > balance Sheet > total Current Assets

3854543000

Quarters > 0 > balance Sheet > property Plant Equipment

1038187000

Quarters > 0 > balance Sheet > total Assets

7614868000

Quarters > 0 > balance Sheet > payables

389670000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

1558157000

Quarters > 0 > balance Sheet > equity

6056711000

Quarters > 0 > balance Sheet > currency_symbol

-

Quarters > 0 > cash Flow > net Income

-30744000

Quarters > 0 > cash Flow > depreciation

18487000

Quarters > 0 > cash Flow > change In Working Capital

118927000

Quarters > 0 > cash Flow > cash From Operations

368685000

Quarters > 0 > cash Flow > capital Expenditures

28447000

Quarters > 0 > cash Flow > cash From Investing

-330963000

Quarters > 0 > cash Flow > cash From Financing

-2169000

Quarters > 0 > cash Flow > net Change In Cash

36292000

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

-0.16009831694717547

Quarters > 0 > ratios > PB

1.934362118318011

Quarters > 0 > ratios > ROE

-0.5076022283381195

Quarters > 0 > ratios > ROA

-0.403736479739373

Quarters > 0 > ratios > FCF

340238000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

0.4383758969145752

Quarters > 0 > health Score

54

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

825410000

Quarters > 1 > income Statement > cost Of Revenue

150090000

Quarters > 1 > income Statement > gross Profit

675320000

Quarters > 1 > income Statement > operating Expenses

398433000

Quarters > 1 > income Statement > operating Income

276887000

Quarters > 1 > income Statement > interest Expense

2679000

Quarters > 1 > income Statement > pretax Income

297868000

Quarters > 1 > income Statement > net Income

240532000

Quarters > 1 > income Statement > eps

1.2231912653895638

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

196643000

Quarters > 1 > income Statement > income Tax Expense

57336000

Quarters > 1 > income Statement > EBITDA

319110000

Quarters > 1 > income Statement > operating Margin

33.54538956397427

Quarters > 1 > income Statement > total Other Income Expense Net

20981000

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

1213816000

Quarters > 1 > balance Sheet > short Term Investments

218309000

Quarters > 1 > balance Sheet > receivables

855855000

Quarters > 1 > balance Sheet > inventories

1340169000

Quarters > 1 > balance Sheet > total Current Assets

3805332000

Quarters > 1 > balance Sheet > property Plant Equipment

1030385000

Quarters > 1 > balance Sheet > total Assets

7456341000

Quarters > 1 > balance Sheet > payables

310797000

Quarters > 1 > balance Sheet > short Term Debt

7704000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

1429228000

Quarters > 1 > balance Sheet > equity

6027113000

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

426218000

Quarters > 1 > cash Flow > depreciation

18563000

Quarters > 1 > cash Flow > change In Working Capital

-158073000

Quarters > 1 > cash Flow > cash From Operations

185271000

Quarters > 1 > cash Flow > capital Expenditures

17101000

Quarters > 1 > cash Flow > cash From Investing

-12592000

Quarters > 1 > cash Flow > cash From Financing

-4603000

Quarters > 1 > cash Flow > net Change In Cash

165013000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

1.2231912653895638

Quarters > 1 > ratios > PB

1.990536668219096

Quarters > 1 > ratios > ROE

3.990832758569484

Quarters > 1 > ratios > ROA

3.225871778128173

Quarters > 1 > ratios > FCF

168170000

Quarters > 1 > ratios > Piotroski FScore

3

Quarters > 1 > ratios > fcf Percent

0.2037411710543851

Quarters > 1 > health Score

75

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

745145000

Quarters > 2 > income Statement > cost Of Revenue

151558000

Quarters > 2 > income Statement > gross Profit

593587000

Quarters > 2 > income Statement > operating Expenses

369694000

Quarters > 2 > income Statement > operating Income

223893000

Quarters > 2 > income Statement > interest Expense

2863000

Quarters > 2 > income Statement > pretax Income

238089000

Quarters > 2 > income Statement > net Income

185686000

Quarters > 2 > income Statement > eps

0.945091971456783

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

196474000

Quarters > 2 > income Statement > income Tax Expense

52403000

Quarters > 2 > income Statement > EBITDA

263021000

Quarters > 2 > income Statement > operating Margin

30.046903622784825

Quarters > 2 > income Statement > total Other Income Expense Net

14196000

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

1048803000

Quarters > 2 > balance Sheet > short Term Investments

223532000

Quarters > 2 > balance Sheet > receivables

739177000

Quarters > 2 > balance Sheet > inventories

1274848000

Quarters > 2 > balance Sheet > total Current Assets

3467905000

Quarters > 2 > balance Sheet > property Plant Equipment

1032613000

Quarters > 2 > balance Sheet > total Assets

7147007000

Quarters > 2 > balance Sheet > payables

293751000

Quarters > 2 > balance Sheet > short Term Debt

6309000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

1353548000

Quarters > 2 > balance Sheet > equity

5793459000

Quarters > 2 > balance Sheet > currency_symbol

-

Quarters > 2 > cash Flow > net Income

185686000

Quarters > 2 > cash Flow > depreciation

22069000

Quarters > 2 > cash Flow > change In Working Capital

-90462000

Quarters > 2 > cash Flow > cash From Operations

174394000

Quarters > 2 > cash Flow > capital Expenditures

16768000

Quarters > 2 > cash Flow > cash From Investing

-28238000

Quarters > 2 > cash Flow > cash From Financing

-38779000

Quarters > 2 > cash Flow > net Change In Cash

105961000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

0.945091971456783

Quarters > 2 > ratios > PB

2.0690366049021836

Quarters > 2 > ratios > ROE

3.205097334770126

Quarters > 2 > ratios > ROA

2.5980945590230986

Quarters > 2 > ratios > FCF

157626000

Quarters > 2 > ratios > Piotroski FScore

3

Quarters > 2 > ratios > fcf Percent

0.2115373517905911

Quarters > 2 > health Score

73

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

747313000

Quarters > 3 > income Statement > cost Of Revenue

136139000

Quarters > 3 > income Statement > gross Profit

611174000

Quarters > 3 > income Statement > operating Expenses

449767000

Quarters > 3 > income Statement > operating Income

161407000

Quarters > 3 > income Statement > interest Expense

2577000

Quarters > 3 > income Statement > pretax Income

169639000

Quarters > 3 > income Statement > net Income

124943000

Quarters > 3 > income Statement > eps

0.6355802442758964

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

196581000

Quarters > 3 > income Statement > income Tax Expense

44696000

Quarters > 3 > income Statement > EBITDA

195496000

Quarters > 3 > income Statement > operating Margin

21.59831288897691

Quarters > 3 > income Statement > total Other Income Expense Net

8232000

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

942842000

Quarters > 3 > balance Sheet > short Term Investments

194864000

Quarters > 3 > balance Sheet > receivables

660535000

Quarters > 3 > balance Sheet > inventories

1232653000

Quarters > 3 > balance Sheet > total Current Assets

3232427000

Quarters > 3 > balance Sheet > property Plant Equipment

1043041000

Quarters > 3 > balance Sheet > total Assets

6988940000

Quarters > 3 > balance Sheet > payables

235403000

Quarters > 3 > balance Sheet > short Term Debt

7574000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

1330950000

Quarters > 3 > balance Sheet > equity

5657990000

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

124943000

Quarters > 3 > cash Flow > depreciation

23607000

Quarters > 3 > cash Flow > change In Working Capital

-83151000

Quarters > 3 > cash Flow > cash From Operations

185627000

Quarters > 3 > cash Flow > capital Expenditures

20299000

Quarters > 3 > cash Flow > cash From Investing

76404000

Quarters > 3 > cash Flow > cash From Financing

2859000

Quarters > 3 > cash Flow > net Change In Cash

267394000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

0.6355802442758964

Quarters > 3 > ratios > PB

2.1197292342333585

Quarters > 3 > ratios > ROE

2.2082577028237944

Quarters > 3 > ratios > ROA

1.7877246048757036

Quarters > 3 > ratios > FCF

165328000

Quarters > 3 > ratios > Piotroski FScore

4

Quarters > 3 > ratios > fcf Percent

0.2212299264163744

Quarters > 3 > health Score

73

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

2853915000

Annuals > 0 > income Statement > cost Of Revenue

580235000

Annuals > 0 > income Statement > gross Profit

2273680000

Annuals > 0 > income Statement > operating Expenses

1789466000

Annuals > 0 > income Statement > operating Income

484214000

Annuals > 0 > income Statement > interest Expense

12666000

Annuals > 0 > income Statement > pretax Income

541763000

Annuals > 0 > income Statement > net Income

426859000

Annuals > 0 > income Statement > eps

2.1700134209081483

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

196708000

Annuals > 0 > income Statement > income Tax Expense

114904000

Annuals > 0 > income Statement > EBITDA

650528000

Annuals > 0 > income Statement > operating Margin

16.966658081968102

Annuals > 0 > income Statement > total Other Income Expense Net

57549000

Annuals > 0 > income Statement > currency_symbol

-

Annuals > 0 > balance Sheet > cash

942842000

Annuals > 0 > balance Sheet > short Term Investments

194864000

Annuals > 0 > balance Sheet > receivables

660535000

Annuals > 0 > balance Sheet > inventories

1232653000

Annuals > 0 > balance Sheet > total Current Assets

3232427000

Annuals > 0 > balance Sheet > property Plant Equipment

1043041000

Annuals > 0 > balance Sheet > total Assets

6988940000

Annuals > 0 > balance Sheet > payables

235403000

Annuals > 0 > balance Sheet > short Term Debt

23071000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

1330950000

Annuals > 0 > balance Sheet > equity

5657990000

Annuals > 0 > balance Sheet > currency_symbol

-

Annuals > 0 > cash Flow > net Income

426859000

Annuals > 0 > cash Flow > depreciation

96426000

Annuals > 0 > cash Flow > change In Working Capital

-216396000

Annuals > 0 > cash Flow > cash From Operations

572841000

Annuals > 0 > cash Flow > capital Expenditures

97418000

Annuals > 0 > cash Flow > cash From Investing

136491000

Annuals > 0 > cash Flow > cash From Financing

-526447000

Annuals > 0 > cash Flow > net Change In Cash

187715000

Annuals > 0 > cash Flow > currency_symbol

-

Annuals > 0 > ratios > PE

2.1700134209081483

Annuals > 0 > ratios > PB

2.1210986728502523

Annuals > 0 > ratios > ROE

7.544357625234404

Annuals > 0 > ratios > ROA

6.1076357788162445

Annuals > 0 > ratios > FCF

475423000

Annuals > 0 > ratios > Piotroski FScore

4

Annuals > 0 > ratios > fcf Percent

0.16658625081686035

Annuals > 0 > health Score

78

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

2419226000

Annuals > 1 > income Statement > cost Of Revenue

532062000

Annuals > 1 > income Statement > gross Profit

1887164000

Annuals > 1 > income Statement > operating Expenses

1701390000

Annuals > 1 > income Statement > operating Income

185774000

Annuals > 1 > income Statement > interest Expense

17335000

Annuals > 1 > income Statement > pretax Income

188563000

Annuals > 1 > income Statement > net Income

167645000

Annuals > 1 > income Statement > eps

0.8749967379106971

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

191595000

Annuals > 1 > income Statement > income Tax Expense

20918000

Annuals > 1 > income Statement > EBITDA

306773000

Annuals > 1 > income Statement > operating Margin

7.679067602613397

Annuals > 1 > income Statement > total Other Income Expense Net

2789000

Annuals > 1 > income Statement > currency_symbol

-

Annuals > 1 > balance Sheet > cash

755127000

Annuals > 1 > balance Sheet > short Term Investments

318683000

Annuals > 1 > balance Sheet > receivables

633704000

Annuals > 1 > balance Sheet > inventories

1107183000

Annuals > 1 > balance Sheet > total Current Assets

2956088000

Annuals > 1 > balance Sheet > property Plant Equipment

1066133000

Annuals > 1 > balance Sheet > total Assets

6841603000

Annuals > 1 > balance Sheet > payables

315509000

Annuals > 1 > balance Sheet > short Term Debt

502656000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

1890054000

Annuals > 1 > balance Sheet > equity

4951549000

Annuals > 1 > balance Sheet > currency_symbol

-

Annuals > 1 > cash Flow > net Income

167645000

Annuals > 1 > cash Flow > depreciation

104386000

Annuals > 1 > cash Flow > change In Working Capital

-336539000

Annuals > 1 > cash Flow > cash From Operations

159259000

Annuals > 1 > cash Flow > capital Expenditures

96691000

Annuals > 1 > cash Flow > cash From Investing

-111244000

Annuals > 1 > cash Flow > cash From Financing

-18727000

Annuals > 1 > cash Flow > net Change In Cash

30596000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

0.8749967379106971

Annuals > 1 > ratios > PB

2.36071801975503

Annuals > 1 > ratios > ROE

3.3857081894978722

Annuals > 1 > ratios > ROA

2.450376030295824

Annuals > 1 > ratios > FCF

62568000

Annuals > 1 > ratios > Piotroski FScore

3

Annuals > 1 > ratios > fcf Percent

0.025862817281229616

Annuals > 1 > health Score

56

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

2096039000

Annuals > 2 > income Statement > cost Of Revenue

503023000

Annuals > 2 > income Statement > gross Profit

1593016000

Annuals > 2 > income Statement > operating Expenses

1432042000

Annuals > 2 > income Statement > operating Income

160974000

Annuals > 2 > income Statement > interest Expense

15970000

Annuals > 2 > income Statement > pretax Income

149576000

Annuals > 2 > income Statement > net Income

141561000

Annuals > 2 > income Statement > eps

0.7491466583405217

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

188963000

Annuals > 2 > income Statement > income Tax Expense

8015000

Annuals > 2 > income Statement > EBITDA

265359000

Annuals > 2 > income Statement > operating Margin

7.679914352738666

Annuals > 2 > income Statement > total Other Income Expense Net

-11398000

Annuals > 2 > income Statement > currency_symbol

-

Annuals > 2 > balance Sheet > cash

724531000

Annuals > 2 > balance Sheet > short Term Investments

567006000

Annuals > 2 > balance Sheet > receivables

461316000

Annuals > 2 > balance Sheet > inventories

894083000

Annuals > 2 > balance Sheet > total Current Assets

2751457000

Annuals > 2 > balance Sheet > property Plant Equipment

1073366000

Annuals > 2 > balance Sheet > total Assets

6375074000

Annuals > 2 > balance Sheet > payables

231238000

Annuals > 2 > balance Sheet > short Term Debt

10375000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

1771918000

Annuals > 2 > balance Sheet > equity

4603156000

Annuals > 2 > balance Sheet > currency_symbol

-

Annuals > 2 > cash Flow > net Income

141561000

Annuals > 2 > cash Flow > depreciation

101969000

Annuals > 2 > cash Flow > change In Working Capital

-96383000

Annuals > 2 > cash Flow > cash From Operations

175902000

Annuals > 2 > cash Flow > capital Expenditures

120959000

Annuals > 2 > cash Flow > cash From Investing

-20029000

Annuals > 2 > cash Flow > cash From Financing

-18650000

Annuals > 2 > cash Flow > net Change In Cash

137255000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

0.7491466583405217

Annuals > 2 > ratios > PB

2.5045061757628893

Annuals > 2 > ratios > ROE

3.075303118121567

Annuals > 2 > ratios > ROA

2.220538930214771

Annuals > 2 > ratios > FCF

54943000

Annuals > 2 > ratios > Piotroski FScore

4

Annuals > 2 > ratios > fcf Percent

0.0262127756210643

Annuals > 2 > health Score

57

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

1846275000

Annuals > 3 > income Statement > cost Of Revenue

470515000

Annuals > 3 > income Statement > gross Profit

1375760000

Annuals > 3 > income Statement > operating Expenses

1458101000

Annuals > 3 > income Statement > operating Income

-82341000

Annuals > 3 > income Statement > interest Expense

15337000

Annuals > 3 > income Statement > pretax Income

-75350000

Annuals > 3 > income Statement > net Income

-64080000

Annuals > 3 > income Statement > eps

-0.35044735633189683

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

182852000

Annuals > 3 > income Statement > income Tax Expense

-11270000

Annuals > 3 > income Statement > EBITDA

47433000

Annuals > 3 > income Statement > operating Margin

-4.459844822683511

Annuals > 3 > income Statement > total Other Income Expense Net

6991000

Annuals > 3 > income Statement > currency_symbol

-

Annuals > 3 > balance Sheet > cash

587276000

Annuals > 3 > balance Sheet > short Term Investments

426599000

Annuals > 3 > balance Sheet > receivables

373399000

Annuals > 3 > balance Sheet > inventories

776669000

Annuals > 3 > balance Sheet > total Current Assets

2274385000

Annuals > 3 > balance Sheet > property Plant Equipment

1035461000

Annuals > 3 > balance Sheet > total Assets

6004772000

Annuals > 3 > balance Sheet > payables

199678000

Annuals > 3 > balance Sheet > short Term Debt

10464000

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

1739103000

Annuals > 3 > balance Sheet > equity

4265669000

Annuals > 3 > balance Sheet > currency_symbol

-

Annuals > 3 > cash Flow > net Income

-64080000

Annuals > 3 > cash Flow > depreciation

108039000

Annuals > 3 > cash Flow > change In Working Capital

66034000

Annuals > 3 > cash Flow > cash From Operations

304536000

Annuals > 3 > cash Flow > capital Expenditures

119225000

Annuals > 3 > cash Flow > cash From Investing

-366313000

Annuals > 3 > cash Flow > cash From Financing

-48000

Annuals > 3 > cash Flow > net Change In Cash

-61882000

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

-0.35044735633189683

Annuals > 3 > ratios > PB

2.6152522664088567

Annuals > 3 > ratios > ROE

-1.5022262627503447

Annuals > 3 > ratios > ROA

-1.0671512590319832

Annuals > 3 > ratios > FCF

185311000

Annuals > 3 > ratios > Piotroski FScore

2

Annuals > 3 > ratios > fcf Percent

0.10037020487197194

Annuals > 3 > health Score

44

Valuation > metrics > PE

2.794

Valuation > metrics > PB

1.934362118318011

Valuation > final Score

100

Valuation > verdict

36.0% Undervalued

Profitability > metrics > ROE

-0.5076022283381195

Profitability > metrics > ROA

-0.7976042814932924

Profitability > metrics > Net Margin

-0.03961176757076429

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.25726124294192015

Risk > metrics > Interest Coverage

-18.10469174098488

Risk > final Score

-12

Risk > verdict

High

Liquidity > metrics > Current Ratio

9.891813585854697

Liquidity > metrics > Quick Ratio

6.344778915492596

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

100

Prev Valuations > 1

100

Prev Valuations > 2

100

Prev Profitabilities > 0

57

Prev Profitabilities > 1

52

Prev Profitabilities > 2

41

Prev Risks > 0

100

Prev Risks > 1

100

Prev Risks > 2

100

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T23:13:31.337Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-02-19

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

AfterMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

0.93

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-